Early Tuesday, the White House budget office circulated a 52-page document as it seeks to implement a sweeping freeze of federal assistance, ...
In a memo dated January 27 from Matthew Vaeth, Acting Director, Office of Management and Budget, sent to the heads of the federal government’s ...
CVS Health (NYSE:CVS), Humana (NYSE:HUM), Molina Healthcare (NYSE:MOH), and UnitedHealth Group (NYSE:UNH) saw an upswing ...
Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...
Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...
UnitedHealth Group Incorporated (NYSE:UNH) dropped its share prices by 6.04 percent on Thursday to end at $510.59 apiece ...